All Stories

  1. Inadequate Reporting of Analytical Characteristics of Biomarkers Used in Clinical Research: A Threat to Interpretation and Replication of Study Findings

    Article • Clinical Chemistry, October 2019, AACC

    David Sacks

  2. Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol

    Article • Clinical Chemistry, February 2018, AACC

    Amy Saenger, David Sacks

  3. Gestational Diabetes Mellitus: Why the Controversy?

    Article • Clinical Chemistry, October 2017, AACC

    David Sacks

  4. Refining Measurement of Hemoglobin A 1c

    Article • Clinical Chemistry, June 2017, AACC

    David Sacks

  5. Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort

    Article • Clinical Chemistry, March 2017, AACC

    David Sacks

  6. Monitoring Glycemic Control in End-Stage Renal Disease: What Should Be Measured?

    Article • Clinical Chemistry, December 2016, AACC

    David Sacks

  7. Glycated Albumin Identifies Prediabetes Not Detected by Hemoglobin A1c: The Africans in America Study

    Article • Clinical Chemistry, September 2016, AACC

    David Sacks

  8. Hemoglobin A1c and Race: Should Therapeutic Targets and Diagnostic Cutoffs Differ among Racial Groups?

    Article • Clinical Chemistry, July 2016, AACC

    David Sacks

  9. Detrimental Effects of Not Using International Reference Materials to Calibrate Cystatin C Assays

    Article • Clinical Chemistry, November 2015, AACC

    David Sacks

  10. Investigation of 2 Models to Set and Evaluate Quality Targets for Hb A1c: Biological Variation and Sigma-Metrics

    Article • Clinical Chemistry, March 2015, AACC

    William John, Erna Lenters-Westra, David Sacks